PD-1 and CTLA-4 are classic examples of inhibitory receptors and in recent years they have received considerable attention because blocking their functions using monoclonal antibodies can be successfully used to increase T cell responses against various cancers (Figure 1a) [3]. Here, PDCD1 is linked to cancer.